NCT04497311 (TOMOCOVIDMX) is a clinical trial of Thoraxic computed tomography in SARS-CoV-2, sponsored by Universidad de Guanajuato.

Who is sponsoring NCT04497311?

NCT04497311 is sponsored by Universidad de Guanajuato.

What drugs are being tested in NCT04497311?

Interventions in NCT04497311: Thoraxic computed tomography.

What condition does NCT04497311 study?

NCT04497311 studies SARS-CoV-2, Covid19, H1N1 Influenza, Computed Tomography.

Is NCT04497311 still recruiting?

NCT04497311 is currently status unknown. Last updated 6 August 2020.

Last reviewed 2020-08-06 · How we verify

NCT04497311: TOMOCOVIDMX

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tomographic Findings in COVID-19 and Influenza

Status unknown Last updated 6 August 2020

What this trial tests

trial testing Thoraxic computed tomography in SARS-CoV-2 in 100 participants. Status unknown.

Timeline

15 June 2020

Primary endpoint
30 April 2021

30 April 2022

Quick facts

Lead sponsor	Universidad de Guanajuato
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	15 June 2020
Primary completion	30 April 2021
Estimated completion	30 April 2022
Sites	1 location across Mexico

Drugs / interventions tested

Thoraxic computed tomography

Conditions studied

SARS-CoV-2 — all drugs for SARS-CoV-2 →
Covid19 — all drugs for Covid19 →
H1N1 Influenza — all drugs for H1N1 Influenza →
Computed Tomography — all drugs for Computed Tomography →

Sponsor

Universidad de Guanajuato — full company profile →

Who can join

Adults 18 to 80, any sex, with SARS-CoV-2 or Covid19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators decided to conduct a longitudinal study that compares the pulmonary tomographic patterns found in patients with viral pneumonia (i.e. influenza H1N1 and SARS-CoV-2) at a regional hospital. The primary aim of this study is to compare the radiological patterns found in patients with COVID-19 and influenza H1N1. The secondary aims of this study will assess the association between the radiological CT pattern and the need for invasive mechanical ventilation and mortality within the first 28 days of intensive care unit admission.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

SARS-CoV-2 versus Influenza A Virus: Characteristics and Co-Treatments.
Wang X, Li J, Liu H, Hu X, et al · · 2023 · cited 7× · PMID 36985154 · DOI 10.3390/microorganisms11030580
Comparison of Tomographic Findings in Patients with Influenza A (H1N1) and COVID-19.
Vélez-Ramírez LN, Jiménez-Zarazúa O, González-Najera LE, Flores-Saldaña GA, et al · · 2025 · PMID 40507002 · DOI 10.3390/diagnostics15111430

Verify or expand the search:

Other recruiting trials for SARS-CoV-2

Currently open trials in the same condition.

NCT07266558 — A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Participants 50 to 64 Years of Age Without Hig · Phase 4 · recruiting
NCT06684379 — Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of A · Phase 1, PHASE2 · recruiting
NCT06585241 — A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations · Phase 4 · recruiting
NCT05876377 — Use and Effectiveness of COVID-19 Vaccines Using State Vaccine Registries and Insurance Claims Data · active not recruiting
NCT05799651 — Safety and Immunogenicity of Glycovax-002 Vaccine in Healthy Adults · Phase 1 · active not recruiting

Other Universidad de Guanajuato trials

Trials by the same sponsor.

NCT06788054 — Intradialysis Exercise Functional Capacity, Body Composition and Survival in Hemodialysis Patients · NA · enrolling by invitation
NCT06667180 — Effects of Low-intensity Transcranial Magnetic Stimulation on Major Depressive Disorder, and on 5-hydroxyindoleacetic Ac · Phase 1, PHASE2 · recruiting
NCT05778266 — Effect of L-citrulline and HIIT on Arterial Stiffness, Body Composition, and Lipid Profile in Adolescents with Steatosis · NA · completed
NCT05162001 — Body Weight Response With Disulfiram in Humans · EARLY_PHASE1 · unknown
NCT04871360 — Effect of L-Citrulline Supplementation on NAFLD in Adolescents With Obesity · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04497311 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad de Guanajuato
Last refreshed: 6 August 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04497311.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing